NCT00184665 - Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes | Biotech Hunter

Enrollment

501

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

insulin detemir

DRUG

insulin NPH

DRUG

insulin aspart

Trial Locations (29)

1000

Novo Nordisk Investigational Site, Skopje

1431

Novo Nordisk Investigational Site, Sofia

2010

Novo Nordisk Investigational Site, Darlinghurst

2065

Novo Nordisk Investigational Site, St Leonards

2193

Novo Nordisk Investigational Site, Johannesburg

3000

Novo Nordisk Investigational Site, Melbourne

3004

Novo Nordisk Investigational Site, Melbourne

4002

Novo Nordisk Investigational Site, Plovdiv

4120

Novo Nordisk Investigational Site, Stones Corner

5011

Novo Nordisk Investigational Site, Woodville

7000

Novo Nordisk Investigational Site, Hobart

16150

Novo Nordisk Investigational Site, Kota Bharu, Kelantan

34390

Novo Nordisk Investigational Site, Istanbul

35100

Novo Nordisk Investigational Site, Bornova-IZMIR

56000

Novo Nordisk Investigational Site, Cheras

600034

Novo Nordisk Investigational Site, Hyderabad

632004

Novo Nordisk Investigational Site, Vellore

Unknown

Novo Nordisk Investigational Site, Buenos Aires

C1405CWB

Novo Nordisk Investigational Site, Ciudad Autonoma de Bs As

C1406FWY

Novo Nordisk Investigational Site, Ciudad Autónoma de BsAs

B7602CBM

Novo Nordisk Investigational Site, Mar del Plata

10 000

Novo Nordisk Investigational Site, Zagreb

600-013

Novo Nordisk Investigational Site, Chennai

400 0067

Novo Nordisk Investigational Site, Mumbai

020042

Novo Nordisk Investigational Site, Bucharest

020475

Novo Nordisk Investigational Site, Bucharest

27 11

Novo Nordisk Investigational Site, Johannesburg

27 21

Novo Nordisk Investigational Site, Cape Town

27 51

Novo Nordisk Investigational Site, Bloemfontein